Rhythm Pharmaceuticals, Inc.
RYTM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001649904
In the last 90 days, Rhythm Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 305 institutions reported holding it in 13F filings for Q2 2026, worth $8.55B in total; Duquesne Family Office is the only superinvestor holding it.
Q4 2022 vs. Q3 2022
How the institutions holding Rhythm Pharmaceuticals, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 101 | 115 | +14 |
| Shares | 59.5M | 62.3M | +2.82M (+4.7%) |
| Value | $1.45B | $1.81B | +$369.1M (+25.5%) |
New holders (26)
Institutions that held Rhythm Pharmaceuticals, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (12)
Institutions that held Rhythm Pharmaceuticals, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Walleye Capital LLC | 191,373 | $4.69M |
| Tudor Investment Corp Et Al | 83,796 | $2.05M |
| Prosight Management, LP | 80,000 | $1.96M |
| UBS Oconnor LLC | 72,375 | $1.77M |
| Ghost Tree Capital, LLC | 65,000 | $1.59M |
| Raymond James & Associates | 22,600 | $554.0K |
| Harvest Investment Services, LLC | 13,941 | $341.0K |
| Macquarie Group Ltd | 5,992 | $200.0K |
| Cutler Group LP | 1,000 | $24.0K |
| IFP Advisors, Inc | 600 | $20.0K |
| Bank of Montreal | 567 | $14.0K |
| Hantz Financial Services, Inc. | 115 | $3.00K |